News
15/11/2013

Bionic implant to treat mental illness under development

UOW researchers are in the midst of developing an innovative brain implant to help treat people with mental illnesses such as schizophrenia.

Professor Xu-Feng Huang, Deputy Executive Director of the Illawarra Health and Medical Research Institute at UOW, is leading a multidisciplinary team of researchers on the $676,000, three-year, National Health and Medical Research Council funded project.

The device will work in a similar way to the cochlear implant, with electrodes implanted into the frontal area of the brain, which will provide electrical stimulation and growth factors to improve brain function in schizophrenia and allied disorders.

“Brain abnormalities in neuronal growth, microstructure and inter-neuronal communication underlie the prefrontal cortical pathology of many psychiatric diseases, including schizophrenia,” Professor Huang said.

Professor Huang recently told the Herald Sun that there had been virtually no technological breakthroughs for the treatment of schizophrenia (which ranks among the top 10 causes of disability in developed countries worldwide) in 50 years.

"Largely we rely on antipsychotics that not only have side-effects but also they can't address the disease effects on cognitive function and communication,” he said.

The collaboration involves Australian Laureate Fellow Professor Gordon Wallace and his team at the ARC Centre of Excellence for Electromaterials Science, who will bring their expertise in new organic materials (polymers), which conduct electricity.

"Through a number of years of study we've proven these materials have many benefits transmitting electrical signals to both nerve and muscle cells, and therefore influencing the developing and behaviour of those cells,” Professor Wallace said.

The team will initially evaluate and optimise the technology in vitro before creating a 3D nano-structured drug-loaded electrical stimulation device that will be tested in animal trials, with the potential to translate to clinical trials.

Professor Huang, who is also the Director of the Centre for Translational Neuroscience at UOW (which has been supported by the Schizophrenia Research Institute since 1999), is working on an additional five National Health and Medical Research Council projects (totalling $3 million) into mental illness.

In fact, a collaboration with China’s Beijing HuiLongGuan Hospital has recently found that that the prevention and treatment of diabetes might prove beneficial for people with schizophrenia and may yield better cognitive functioning, especially in immediate memory and attention.

By Elise Pitt

UOW IN THE NEWS 

UOW reveals 20 year vision in cam...
Illawarra Mercury | 23 August
Sweat lodges: harmful or healing?
Body & Soul | 23 August
How to get a better bang for the...
The Conversation | 23 August
New modelling on bushfires shows...
The Conversation | 22 August
The prejudices failing male nurses...
ABC News | 20 August
Good corporate governance is...
The Conversation | 17 August
‘I’m an Olympian now’: How Sy ...
Daily Telegraph | 16 August

Virtual reality trip inside cancer c...
SMH | 16 August
In the mind of an elite athlete...
The Conversation |16 August
Fishing, not oil, is at the hear...
The Conversation |16 August
Ansell shares aroused by poten...
SMH | 15 August
Australian Museum Science Fes...
SMH | 14 August
Meet the high-school dunces w...
News.com.au | 14 August
Census failure blamed on denial...
Illawarra Mercury | 10 Aug
Who can watch whom under...
2SER | 5 August 
Reimagining NSW: tackling ...

The Conversation | 4 August
The traditionalists are restless...
The Conversation | 3 August
iPhone hackers still wiping dig...
SMH | 3 August
Scientists use oxygen 'scissor...

Phys.org | 1 August
Wollongong study uncovers ...
ABC online | 1 August
Latimore graduates into bus...
Daily Telegraph | 28 July
iPad screen time can be goo...
SMH | 27July 
Like Pokemon, Wollongong...

The Australian | 27 July
More media coverage

  • Professor Xu-Feng Huang and his team are developing an innovative bionic implant to help treat people with mental illnesses such as schizophrenia.